Charter Research & Investment Group, Inc. Bristol Myers Squibb CO Transaction History
Charter Research & Investment Group, Inc.
- $131 Million
- Q4 2024
A detailed history of Charter Research & Investment Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Charter Research & Investment Group, Inc. holds 39,658 shares of BMY stock, worth $2.37 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
39,658
Previous 41,420
4.25%
Holding current value
$2.37 Million
Previous $2.14 Million
4.67%
% of portfolio
1.71%
Previous 1.58%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.5 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.75 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.7 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.61 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...